1
Lauren Pearce
Student
Stephenson Cardiac Imaging Centre
Calgary, Alberta, Canada
Lauren Pearce
Student
Stephenson Cardiac Imaging Centre
Calgary, Alberta, Canada
Chiara Coletti, MSc
PhD student
TU Delft
Delft, Zuid-Holland, Netherlands
Jacqueline Flewitt, MSc
Research Collaborations Coordinator
Libin Cardiovascular Institute of Alberta, University of Calgary
Calgary, Alberta, Canada
Jian Nong Wu, RT
Technologist
Stephenson Cardiac Imaging Centre, Canada
Rita Lam, RT
Technologist
Stephenson Cardiac Imaging Centre, Canada
Andrew G. Howarth, MD, PhD
Clinical Co-director
Libin Cardiovascular Institute of Alberta, University of Calgary
Calgary, Alberta, Canada
Carmen P. Lydell, MD
Clinical Co-director
Libin Cardiovascular Institute of Alberta, University of Calgary
Calgary, Alberta, Canada
James White, MD
Professor of Cardiology
Stephenson Cardiac Imaging Centre
Calgary, Alberta, Canada
Sebastian Weingartner, PhD
Assistant Professor
Delft University of Technology
Delft, Zuid-Holland, Netherlands
Kelvin Chow, PhD
Staff Scientist
Siemens Healthineers
Chicago, Illinois, United States
Late gadolinium enhancement (LGE) is widely used to visualize extracellular volume changes that occur in a variety of pathologies, such as regional replacement fibrosis or edema. Non-contrast evaluation by parametric mapping may reduce exam time, cost, and obviate contrast administration.
T1ρ has been proposed to be more sensitive to collagen content of fibrosis-based pathology, providing complimentary information to existing T1 and T2 mapping, potentially discriminating causes of ECV expansion such as infiltrates or edema (1). Adiabatic T1ρ pulses have improved robustness to B0/B1 inhomogeneities compared to conventional spin-lock (2,3) and may enable 3T imaging. The mSASHA sequence (4) can be extended for simultaneous T1, T2 and adiabatic T1ρ mapping in a single breath-hold.
Methods:
The prototype mSASHA sequence comprises a set of images with variable T1, T1+T2, and T1+T1ρ weighting acquired in a 15-heartbeat breath-hold with maps jointly calculated from all images (Fig 1). T1ρ preparation was achieved with 2 adiabatic hyperbolic secant pulses with β=3.5-7.0, ƒmax=1600-1650Hz, duration = 30 ms each, max B1+ ≥15 uT (3).
Twenty-three patients (55 ± 19 yrs, 17 male) referred for clinical CMRs were enrolled and scanned at 3T (MAGNETOM Prisma or Skyra, Siemens Healthcare, Germany). Patients had one or more diagnoses: 22% hypertrophic cardiomyopathy, 48% coronary artery disease, 9% amyloidosis, 13% myocarditis, 17% other. Imaging included non-contrast mSASHA, bSSFP cine, and LGE following 0.1 mmol/kg contrast (Gadovist, Bayer HealthCare Pharmaceuticals, USA).
Focal lesions and remote myocardium were identified on LGE and corresponding ROIs were drawn on mSASHA maps. Relative percent change between lesions and remote areas were compared across T1, T2 and T1ρ maps.
Results:
mSASHA mapping was successful in all subjects without visible B0/B1 related artifacts. LGE-identified pathology was present in 83% of patients and 83% of LGE lesions were visible in at least one of the parametric maps. Pathological regions showed larger relative elevations in T1ρ compared to remote than T2 and T1 with respective changes of 30 ± 40%, 21 ± 27% and 12 ± 11%. However, some LGE findings showed no T1ρ changes despite elevation on T1 or T2.
In one study (Fig. 2), multi-vessel chronic infarction accompanied multi-focal septal injury on LGE suspected to be of embolic origin. The latter showed marked elevations in T1ρ and T2 and patchy T1 elevations. Another example of acute coronary syndrome showed diffuse patchy enhancement of the LAD territory corresponding to marked elevations in T1 and T2 with mildly elevated T1ρ (Fig. 3).
Conclusion:
Non-contrast multi-parametric mSASHA with simultaneous T1ρ, T1 and T2 is clinically feasible at 3T and LGE lesions generally had greater T1ρ contrast than T1 or T2. Heterogenous presentation on maps suggests this approach may sub-differentiate etiology of LGE lesions. Further optimization of T1ρ pulses may improve its sensitivity and specificity for certain pathologies.